Medirom Healthcare Technologies Inc. MRM
Other Consumer Services · IPO 2020 · data as of November 13, 2026
Medirom Healthcare Technologies Inc. (MRM) is a consumer discretionary company listed in the US with a market value of about $2M. In fiscal year 2024 it had revenue of $53M and net income of $947837, a net margin of 1.8%.
Its overall Stock Analiz score is 1.0 out of 5 (weak). The strongest part is value (3/5); the weakest is future growth (0/5).
Key numbers: a P/E of 2.3, 5-year revenue growth of 8% a year, a 5-year average ROIC of -8%.
About Medirom Healthcare Technologies
Medirom Healthcare Technologies is listed in the US and classified in other consumer services, IPO year 2020. Revenue went from $36M in 2019 to $53M in 2024, growth of about 8.0% a year. It was profitable in 4 of the last 6 years in our data.
Score: 1.0 / 5
Checks passed
- P/E below 25
- P/E below the industry median
- PEG below 1.5
- 5-year EPS growth above 10% a year
- ROE above 15%
Checks not passed
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Profit margin improving
- 3-year free cash flow growth above 10% a year
- Strong R&D investment or growth above 20%
- 5-year revenue growth above 8% a year
Valuation
Growth and quality
Financials, last 6 years
| Fiscal year | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | $53M | $48M | $53M | $47M | $32M | $36M |
| Net income | $947837 | $815691 | $1M | -$9M | -$5M | $159696 |
| Free cash flow | -$9M | -$5M | -$6M | -$6M | -$4M | $4275 |
| EPS (diluted) | $0.12 | $0.10 | $0.14 | $-1.09 | $-0.66 | $0.02 |
| Net margin | 1.8% | 1.7% | 2.1% | -18.3% | -16.1% | 0.4% |
| ROIC | -0.3% | -8.9% | 2.5% | -14.4% | -21.0% | 0.6% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
Frequently asked questions
What is Medirom Healthcare Technologies’s P/E ratio?
About 2.3, based on the last twelve months of diluted earnings per share.
Does Medirom Healthcare Technologies pay a dividend?
Not currently.
Is Medirom Healthcare Technologies a good stock to buy?
We do not give buy or sell advice. Medirom Healthcare Technologies scores 1.0 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.